Abstract
Trifluridine/tipiracil (FTD/TPI; marketed as Lonsurf (R)) has shown clinically relevant activity after fluoropyrimidine failure in colorectal cancer a......
小提示:本篇文献需要登录阅读全文,点击跳转登录